What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...

Indegene announced a strategic partnership with CliniOps, a leading provider of advanced digital clinical trial solutions to drive innovative digital transformation in clinical trial processes and ...

With a client base that includes the world's top 20 pharma companies, Indegene brings a strong track record of modernizing the industry with its deep domain expertise and life sciences-contextualized ...

Before investing in a stock, investors should conduct thorough checks, focusing on the business, financials, management, and ...

In the latest market close, Veeva Systems (VEEV) reached $217.75, with a +0.21% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 1.54%. On ...

A new wave of visionary entrepreneurs is here to reshape the business landscape with more than financial success—they’re ...

Enveda, a biotechnology company using AI to translate life's chemistry into new medicines, today announced the appointment of Jason Kim as Chief Financial Officer (CFO). Mr. Kim brings more than 20 ...

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Putin is doing this to scare you. He wants you to be afraid even to mention Alexei and gradually forget his name’ ...